We are live on ! Find out more
ACM

AH Capital Management Portfolio holdings

AUM $1.29B
1-Year Est. Return 26.81%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
-26.81%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$701M
AUM Growth
-$44.4M
Cap. Flow
+$22.4M
Cap. Flow %
3.19%
Top 10 Hldgs %
99.31%
Holding
13
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MAZE
Maze Therapeutics
MAZE
+$20.5M
2
CYN icon
Cyngn
CYN
+$1.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 41.65%
2 Technology 29.77%
3 Healthcare 22.3%
4 Industrials 5.38%
5 Real Estate 0.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DASH icon
1
DoorDash
DASH
$79.8B
$292M 41.65%
1,597,010
– –
IOT icon
2
Samsara
IOT
$20.6B
$153M 21.85%
3,995,652
– –
RVMD icon
3
Revolution Medicines
RVMD
$40.2B
$97.2M 13.87%
2,748,523
– –
XYZ
4
Block Inc
XYZ
$47.2B
$55.2M 7.88%
1,016,697
– –
ACCD
5
DELISTED
Accolade Inc
ACCD
$37.7M 5.38%
5,398,708
– –
MAZE
6
Maze Therapeutics
MAZE
$1.58B
$18.7M 2.67%
+1,702,225
New +$20.5M
NAUT icon
7
Nautilus Biotechnolgy
NAUT
$212M
$15.2M 2.17%
17,653,917
– –
BIOA
8
BioAge Labs
BIOA
$975M
$12.2M 1.73%
3,233,170
– –
CAMP icon
9
CAMP4 Therapeutics
CAMP
$164M
$8.5M 1.21%
2,125,339
– –
OPEN icon
10
Opendoor
OPEN
$3.72B
$6.32M 0.9%
6,407,515
– –
ERAS icon
11
Erasca
ERAS
$6.7B
$3.92M 0.56%
2,862,500
– –
DNA icon
12
Ginkgo Bioworks
DNA
$481M
$619K 0.09%
108,568
– –
CYN icon
13
Cyngn
CYN
$16M
$261K 0.04%
57,584
+57,200
+14,896% +$1.9M

Similar funds

PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
ACM
Alta Capital Management Salt Lake City, Utah $1.29B AUM 17.57% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
MA
MONECO Advisors Fairfield, Connecticut $1.29B AUM 18.01% 1-Year Est. Return
CTA
Colonial Trust Advisors Spartanburg, South Carolina $1.29B AUM 19.9% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return

AH Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, AH Capital Management held 13 positions worth $701M, down 6% from $745M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

AH Capital Management deployed $22.4M of net new capital in Q1 2025, opening 1 new position and adding to 1 existing holding. Its largest new stake was Maze Therapeutics: 1,702,225 shares worth $18.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 42% of assets, up from 36% a quarter earlier, followed by Technology and Healthcare.

  • AH Capital Management's largest Q1 2025 buy was Maze Therapeutics: 1,702,225 shares worth $18.7M.
  • AH Capital Management added most to Cyngn in Q1 2025, an estimated $1.9M increase.
  • AH Capital Management's ten largest holdings make up 99% of its $701M portfolio in Q1 2025.
  • AH Capital Management opened 1 new position and closed 0 in Q1 2025.
  • AH Capital Management's portfolio value fell 6% quarter-over-quarter to $701M.

Based on AH Capital Management's 13F filing for Q1 2025, filed 15 May 2025.